Viral Vaccines Market: Introduction

  • Vaccines are biological preparations, generally produced from living organisms, which enhance immunity against a particular disease. Vaccines that prevent occurrence of a disease are called prophylactic vaccines and in some cases, those that treat diseases are called therapeutic vaccines.
  • A vaccine is usually made from a weakened or killed form of the disease-causing microorganism
  • Viral vaccines contain killed or attenuated virus or their product that can activate the immune system to produce antibodies against them. The five types of viral vaccines are: live whole viral vaccine, killed whole viral vaccine, subunit vaccine (purified or recombinant viral antigen), anti-idiotype antibodies, and DNA vaccine.
  • Live viral vaccines are prepared by reducing virulence of pathogen, but keeping it alive. Killed viral vaccine consist of virus particle grown on culture and subsequently killed by using heat or formaldehyde. Subunit vaccines (purified or recombinant viral antigen) are created by exposing viral particle in bacteria, yeast, or mammalian cell (an alternative application of recombinant DNA technology for production of hybrid virus vaccines). Anti-idiotype antibodies have the ability to mimic foreign antigen approach that leads to their development as vaccine in order to induce immunity against virus in experimental animals. DNA vaccination involves direct introduction of genetically engineered DNA so that cells directly produce an antigen.

Key Drivers and Restraints of Global Viral Vaccines Market

  • Rise in prevalence of several infectious and non-infectious disease and technological advancements are projected to drive the global viral vaccines market during the forecast period
  • According to the World Health Organization (WHO), various disease vaccines are in pipeline and undergoing clinical trials. Rise in number of vaccines in pipeline is expected to propel the global viral vaccines market.
  • Additionally, a large number of vaccination programs, government and non-government initiatives, and an increase in the demand for combined vaccine boost the market
  • However, the cost associated with storage and transportation of vaccines and limited reimbursement coverage are projected to restrain the global viral vaccines market during the forecast period
  • Stringent government regulation for the approval of biological products is also likely to hamper the market in the next few years

North America to Lead Global Viral Vaccines Market

  • In terms of region, the global viral vaccines market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa
  • North America is expected to account for a notable share of the global market from 2020 to 2031, due to an increase in initiatives by the United States Department of Health and Human Services (HHS). This is a key factor that encourages immunization programs in the U.S.
  • Europe is expected to be the second-largest market for viral vaccines during the forecast period, due to a rise in prevalence of infectious diseases, government initiatives, and focused product development in the region
  • The viral vaccines market in Asia Pacific is expected to expand rapidly during the forecast period. Expansion of the market in the region is attributed to an increase in awareness about prevention of viral diseases, rapidly development of healthcare infrastructure, and a surge in adoption of technology in the region.
  • Governments in Latin America and Middle East & Africa are taking initiatives in research & development of vaccines, which in turn is estimated to fuel the market in these regions at a moderate pace during the forecast period
  • Economic development in countries in Africa is considerably sluggish; hence, the market in the region is projected to expand at a low growth rate during the forecast period

Key Players Operating in Global Viral Vaccines Market

Key players operating in the global viral vaccines market are:

  • Seqirus (CSL Limited)
  • Merck & Co., Inc.
  • AstraZeneca plc
  • Emergent BioSolutions Inc.
  • Novartis, Inc.
  • GlaxoSmithKline plc
  • Pfizer, Inc.
  • Sanofi
  • Serum institute of India Private Limited
  • Novavax, Inc.

Global Viral Vaccines Market: Research Scope

Global Viral Vaccines Market, by Type

  • Preventive Vaccine
  • Therapeutic Viral

Global Viral Vaccines Market, by Indication

  • Influenza
  • Hepatitis
  • Chickenpox
  • Smallpox
  • Human Papillomavirus Infection
  • Measles
  • Rabies
  • Polio Or Poliomyelitis
  • Respiratory Syncytial Virus (RSV)
  • Others

Global Viral Vaccines Market, by Route of Administration

  • Oral
  • Injectable

Global Viral Vaccines Market, by End-user

  • Hospital
  • Clinics
  • Physician's Office
  • Others

Global Viral Vaccines Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Viral Vaccines Market